Buscar
Tevogen Bio Holdings Inc
TVGNAñadir a la lista de seguimiento
6.690USD
-0.030-0.45%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
537.98KCap. mercado
PérdidaP/E TTM
Más Datos de Tevogen Bio Holdings Inc Compañía
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Información de Tevogen Bio Holdings Inc
Símbolo de cotizaciónTVGN
Nombre de la empresaTevogen Bio Holdings Inc
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoSaadi (Ryan)
Número de empleados18
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 04
Dirección15 Independence Boulevard, Suite #210
CiudadWARREN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07059
Teléfono16468078832
Sitio Webhttps://tevogen.com/
Símbolo de cotizaciónTVGN
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoSaadi (Ryan)
Ejecutivos de Tevogen Bio Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Dr. Ryan Saadi, M.D.
Dr. Ryan Saadi, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Curtis Patton
Dr. Curtis Patton
Independent Director
Independent Director
--
--
Mr. Victor Sordillo
Mr. Victor Sordillo
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Tevogen Bio Holdings Inc?
Los cinco principales accionistas de Tevogen Bio Holdings Inc son: Mr. Kirti Desai
¿Cuántas instituciones poseen acciones de Tevogen Bio Holdings Inc (TVGN)?
A fecha de 2026Q1, 115 instituciones poseen acciones de Tevogen Bio Holdings Inc, con un valor de mercado combinado de aproximadamente 168.15K, lo que representa el 4.02% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -44192.00.